Moderna

Associate Director, Field Medical Advisor (Sr. MSL), Texas

United States

Moderna Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess a Doctor of Pharmacy (PharmD) degree or equivalent, along with a strong understanding of pharmaceutical sales and medical affairs. A minimum of 8 years of experience in medical affairs, specifically within a field medical advisor role, is required, with demonstrated success in Texas, Louisiana, and Arkansas preferred. Experience with mRNA technology or vaccines is highly desirable. Excellent knowledge of US healthcare systems, regulatory guidelines, and medical terminology is essential.

Responsibilities

As an Associate Director, Field Medical Advisor, you will be responsible for developing and executing territory engagement plans to share Moderna’s science and data effectively with the medical and healthcare community. You will utilize excellent communication skills to simplify complex scientific topics and gather insights from healthcare professionals, including Key Opinion Leaders and scientific societies. This role involves strategic engagement, medical intelligence gathering, stakeholder interaction, scientific dialogue, and the management of medical strategies, including advisory boards and conferences. Furthermore, you will ensure compliance with ethical standards and accurately document activities in the CRM system, reporting adverse events and product quality complaints, while collaborating to enhance patient care and outcomes.

Skills

Scientific Communication
Strategic Planning
Healthcare Ecosystem Knowledge
Scientific Data Sharing
Digital Engagement
Generative AI
Relationship Building
Medical Intelligence

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Key Metrics

Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
401(k) Company Match
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.
Possible removal from Nasdaq 100 Index could affect investor confidence.
Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.
The company integrates AI to optimize mRNA design and production processes.
Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.
The company is expanding mRNA applications to personalized cancer vaccines.
Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI